Healthy Patients

Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Healthcare professionals who wish to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Medical Microbiologists, Infectiologists and other specialists
- General Practitioners, Pharmacists
- Infection Prevention Experts and nurses
- Medical Docters and Caretakers in nursing homes
- Managers and Labtechnicians of Microbiological Laboratories.
Latest Topics
-
16 September 2025
Irresistible: developing new solutions for antimicrobial resistant STIs
This report warns that antimicrobial resistance (AMR) is a growing public health threat, particularly for sexually transmitted infections (STIs) such as gonorrhoea, Mycoplasma genitalium and trichomoniasis. Gonorrhoea is already classified as multidrug resistant, while the others are showing increasing resistance. Without better diagnostics and vaccines, even new antimicrobials will quickly face resistance, leaving few effective […]
Read more... -
09 September 2025
The Take 5 Campaign: Effects of an Intervention to Promote Five-Day Durations of Antibiotic Therapy for Common Infections in Urgent Care
This quasi-experimental study evaluated the Take 5 campaign, an intervention promoting five-day antibiotic courses for common infections in urgent care. Conducted at two centers (2017–2023), it targeted skin infections, UTIs, sinusitis, otitis media, pneumonia, and COPD exacerbations. The campaign led to an immediate 10.7% rise in ≤5-day prescriptions and a continued monthly increase, raising adherence […]
Read more... -
28 August 2025
PAHO calls for strengthened vaccination and surveillance amid the spread of antibiotic-resistant pertussis in the Americas
The Pan American Health Organization (PAHO) has raised alarm over a sharp resurgence of pertussis (whooping cough) in the Americas and the rise of antibiotic-resistant Bordetella pertussis strains. Reported cases surged from 4,139 in 2023 to 43,751 in 2024, with nearly 19,000 cases and 128 deaths already in the first seven months of 2025. Key […]
Read more...
More news related to Healthy patients